Market Tracker

06/22 5:15pm ET

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

7.10
Delayed Data
As of Jun 22
 -0.35 / -4.70%
Today’s Change
5.20
Today|||52-Week Range
24.25
-55.06%
Year-to-Date
No recent news for Melinta Therapeutics, Inc..

Today’s Trading

Previous close7.45
Today’s open7.45
Day’s range7.00 - 7.50
Volume813,865
Average volume (3 months)309,909
Market cap$244.6M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-86.84%
Earnings growth (this year)+79.23%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.97%
P/E ratio0.0
Price/Sales1.67
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...-0.05-1.23%
CDMOAvid Bioservices Inc+0.26+7.95%
RDHLRedhill Biopharma Lt...+0.06+0.77%
TRVNTrevena Inc-0.04-2.40%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$33.9M
Annual profit (last year)-$58.9M
Net profit margin-173.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Daniel Mark Wechsler
CFO, Secretary &
Principal Accounting Officer
Paul Estrem
Corporate headquarters
New Haven, Connecticut

Forecasts